Literature DB >> 8864401

Ornithine decarboxylase levels in patients with normal colonic mucosa.

E Zehnter1, U Roisch, W Kruis, C Breuer, V Diehl.   

Abstract

We describe a systematic examination of ornithine decarboxylase activity in 120 colonic mucosal samples which were obtained from 20 subjects without colonic disease to establish the normal mean and standard deviation from proximal to distal colon. Ornithine decarboxylase activity was determined by releasing CO2 from DL-[1-14C]ornithine. The mean ornithine decarboxylase levels (CO2 liberated) ranged from 0.26 +/- 0.08 nmol/h.mg protein in the caecum to 0.44 +/- 0.16 nmol/h.mg protein in the rectum. There was no difference between sex and age. Ornithine decarboxylase was not stimulated by guanosine 5'-triphosphate. alpha-Difluoromethylornithine showed an ornithine decarboxylase inhibition of 97.1%. Ornithine decarboxylase activity can be measured with reliable precision and reproducibility. The knowledge of the normal range of ornithine decarboxylase activity in normal human colonic mucosa is necessary for the determination of ornithine decarboxylase activity in pathological findings, especially in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864401     DOI: 10.1515/cclm.1996.34.7.529

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  3 in total

1.  Do biofilms confer a pro-carcinogenic state?

Authors:  Christine M Dejea; Cynthia L Sears
Journal:  Gut Microbes       Date:  2016

2.  Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features.

Authors:  Hubert Allgayer; Ulla Roisch; Elmar Zehnter; Dieter J Ziegenhagen; Hans P Dienes; Wolfgang Kruis
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

3.  Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.

Authors:  J M Bae; J H Kim; N-Y Cho; T-Y Kim; G H Kang
Journal:  Br J Cancer       Date:  2013-07-30       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.